These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35351598)

  • 41. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
    Xie L; Hu X; Li Y; Zhang W; Chen L
    Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DOCK8 deficiency: Insights into pathophysiology, clinical features and management.
    Biggs CM; Keles S; Chatila TA
    Clin Immunol; 2017 Aug; 181():75-82. PubMed ID: 28625885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).
    Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Hsieh MY; Huang YC; Kuo HC; Yang KD; Yu HR; Jaing TH; Yang CH
    J Clin Immunol; 2011 Apr; 31(2):272-80. PubMed ID: 21120687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ten-year follow-up of a DOCK8-deficient child with features of systemic lupus erythematosus.
    Jouhadi Z; Khadir K; Ailal F; Bouayad K; Nadifi S; Engelhardt KR; Grimbacher B
    Pediatrics; 2014 Nov; 134(5):e1458-63. PubMed ID: 25332498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
    Paulson ML; Freeman AF; Holland SM
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes T
    Keles S; Charbonnier LM; Kabaleeswaran V; Reisli I; Genel F; Gulez N; Al-Herz W; Ramesh N; Perez-Atayde A; Karaca NE; Kutukculer N; Wu H; Geha RS; Chatila TA
    J Allergy Clin Immunol; 2016 Nov; 138(5):1384-1394.e2. PubMed ID: 27350570
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DOCK8 mutation diagnosed using whole-exome sequencing of the dried blood spot-derived DNA: a case report of an Iraqi girl diagnosed in Japan.
    Al-Kzayer LFY; Al-Aradi HMH; Shigemura T; Sano K; Tanaka M; Hamada M; Ali KH; Aldaghir OM; Nakazawa Y; Okuno Y
    BMC Med Genet; 2019 Jun; 20(1):114. PubMed ID: 31242861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The hyper-IgE syndromes.
    Freeman AF; Holland SM
    Immunol Allergy Clin North Am; 2008 May; 28(2):277-91, viii. PubMed ID: 18424333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel DOCK8 gene mutations lead to absence of protein expression in patients with hyper-IgE syndrome.
    Qin T; An Y; Liu C; Wu J; Dai R; Liu D; Li X; Jiang L; Wu D; Tang X; Song W; Wang T; Zhao X
    Immunol Res; 2016 Feb; 64(1):260-71. PubMed ID: 26659092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous manifestations of DOCK8 deficiency syndrome.
    Chu EY; Freeman AF; Jing H; Cowen EW; Davis J; Su HC; Holland SM; Turner ML
    Arch Dermatol; 2012 Jan; 148(1):79-84. PubMed ID: 21931011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Severe atopic dermatitis caused by rare immunodeficiency in childhood].
    Wolsk HM; Marquart HV; Laub B; Gniadecki R; Nysom K; Ifversen M
    Ugeskr Laeger; 2015 Dec; 177(51):V06150498. PubMed ID: 26692033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Omalizumab in the Treatment of Hyper-IgE Syndrome: 2 Case Reports.
    Gomes N; Miranda J; Lopes S; Carneiro-Leão L; Torres Costa J; Baudrier T; Azevedo F
    J Investig Allergol Clin Immunol; 2020; 30(3):191-192. PubMed ID: 31820738
    [No Abstract]   [Full Text] [Related]  

  • 53. An Update on Syndromes with a Hyper-IgE Phenotype.
    Bergerson JRE; Freeman AF
    Immunol Allergy Clin North Am; 2019 Feb; 39(1):49-61. PubMed ID: 30466772
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel large deletion of the DOCK8 gene in a Chinese family with autosomal-recessive hyper-IgE syndrome.
    Xue L; Yang Y; Wang S
    J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):599-601. PubMed ID: 24673638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exome-first Approach Identified Novel Homozygous Dedicator of Cytokinesis 8 (DOCK8) Mutations in Three Unrelated Iranian Pedigrees Suspected with Hyper-IgE Syndrome.
    Aghebati-Maleki A; Shahani T; Momen T; Alyasin S; Changi-Ashtiani M; Biglari A; Shahrooei M; Javanian AS; Amini S; Bossuyt X; Rokni-Zadeh H
    Iran J Allergy Asthma Immunol; 2020 Apr; 19(2):193-199. PubMed ID: 32372632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical and laboratory spectrum of dedicator of cytokinesis 8 immunodeficiency syndrome in patients with a unique mutation.
    Broides A; Mandola AB; Levy J; Yerushalmi B; Pinsk V; Eldan M; Shubinsky G; Hadad N; Levy R; Nahum A; Ben-Harosh M; Lev A; Simon A; Somech R
    Immunol Res; 2017 Jun; 65(3):651-657. PubMed ID: 28070732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
    Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
    J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Somatic alterations compromised molecular diagnosis of DOCK8 hyper-IgE syndrome caused by a novel intronic splice site mutation.
    Hagl B; Spielberger BD; Thoene S; Bonnal S; Mertes C; Winter C; Nijman IJ; Verduin S; Eberherr AC; Puel A; Schindler D; Ruland J; Meitinger T; Gagneur J; Orange JS; van Gijn ME; Renner ED
    Sci Rep; 2018 Nov; 8(1):16719. PubMed ID: 30425284
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical, immunological and genetic features in Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).
    Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Ou LS; Yao TC; Hsieh MY; Huang YC; Yu HR; Kuo HC; Yang KD; Jaing TH
    Immunobiology; 2011 Aug; 216(8):909-17. PubMed ID: 21324546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.
    Shamriz O; Rubin L; Simon AJ; Lev A; Barel O; Somech R; Korem M; Matza Porges S; Freund T; Hagin D; Garty BZ; Nahum A; Molho Pessach V; Tal Y
    Front Immunol; 2022; 13():1044933. PubMed ID: 36605204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.